Compare · BBNX vs MDLN
BBNX vs MDLN
Side-by-side comparison of Beta Bionics Inc. (BBNX) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BBNX and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $54.99B, about 117.5x BBNX ($467.9M).
- Over the past year, BBNX is down 29.8% and MDLN is up 3.1% - MDLN leads by 32.9 points.
- MDLN has been more active in the news (10 items in the past 4 weeks vs 4 for BBNX).
- MDLN has more recent analyst coverage (25 ratings vs 16 for BBNX).
PerformanceBBNX-64.06%MDLN+3.09%
2025-12-17+0.00%2026-05-07
- Company
- Beta Bionics Inc.
- Medline Inc.
- Price
- $10.49-0.80%
- $42.01+0.14%
- Market cap
- $467.9M
- $54.99B
- 1M return
- +7.04%
- -5.32%
- 1Y return
- -29.79%
- +3.09%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2025
- News (4w)
- 4
- 10
- Recent ratings
- 16
- 25
Latest BBNX
- Beta Bionics to Present at the Bank of America Securities Health Care Conference
- SEC Form 10-Q filed by Beta Bionics Inc.
- Beta Bionics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
- SEC Form DEFA14A filed by Beta Bionics Inc.
- SEC Form DEF 14A filed by Beta Bionics Inc.
- Beta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes Care
- Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by Beta Bionics Inc.
- Chief Medical Officer Russell Steven Jon sold $30,069 worth of shares (1,025 units at $29.34), decreasing direct ownership by 0.57% to 178,071 units (SEC Form 4)
Latest MDLN
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- SEC Form 10-Q filed by Medline Inc.
- Medline Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Medline Reports First Quarter 2026 Results
- Medline officially launches Mpower™, a digital control tower designed to predict, respond and resolve supply chain risks
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- SEC Form DEFA14A filed by Medline Inc.
- SEC Form DEF 14A filed by Medline Inc.
- Medline announces first-in-healthcare AI robotics partnership with Symbotic